semaglutide california ban update Minnesota doctor says FDA weight-loss drug cutoff is 'devastating' for patients The Refill, Issue 5: FDA

That should be an advantage in really getting the drug to a much wider population. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing

Mayo Clinic Health Matters Podcast (March 2026) on GLP-1 weight loss medications covering side effects, nutritional considerations, muscle loss (muscle preservation is a key concern), and what patients should discuss with their doctors

When we checked that audience against verified ICD-10 diagnosis data, fewer than 40,000 were real patients

However, for vegetarians or vegans, meeting this requirement is much more challenging since plant-based foods contain very little L-Carnitine

Commercial revised policies effective Feb